INC Research Acquires NDDO Oncology
03 January 2006
Leading therapeutically specialized contract research organization expands its global oncology expertise with acquisition of top European anticancer drug development company.
Raleigh, NC – December 1, 2005 – INC Research announced today that the company has acquired NDDO Oncology, BV, a highly respected and experienced global Contract Research Organization (CRO) known as a leader in the field of anticancer drug development.
"With the addition of NDDO Oncology, INC Research becomes a predominant global leader in our therapeutically specialized service sector", stated Jim Ogle, CEO of INC Research. "Our Pharma and Biotech customers are focused on finding outsourcing partners with both specialized expertise and access to experienced investigators. NDDO’s renowned oncology capabilities and strong ties to oncology investigators and thought leaders worldwide bring considerable strategic value to our organization and will have an immediate impact on the level of specialized expertise and service we can offer our customers. It’s a pleasure to welcome NDDO Oncology into the INC Research fold, and Coen van Kalken, MD, their founding CEO onto the INC Research Board of Directors".
Kelvin Logan, PhD, President of INC Research Europe said, "The managing executives of NDDO Oncology and their entire team will be a real asset to INC Research. I am confident they will quickly become an integral part of INC Research, augmenting the depth of scientific, clinical and regulatory expertise represented within our company. We are pleased to add this strong base of clinical operations in the Netherlands and additional expertise in early phase Oncology clinical studies in Europe".
"From the beginning, we developed NDDO Oncology as a CRO dedicated to high quality international development of anticancer drugs and therapies" said Eric van der Putten, CEO of NDDO Oncology. "Our top priority has been providing the highest quality of customer service. As the needs of our pharmaceutical and biotech clients have demanded even more robust, full-service global capabilities, we strove to meet that increasing need. Joining with INC Research allowed us to do so. Innovation, quality and service are the hallmarks of both companies. We are pleased to be a part of INC Research".
